CN Patent
CN103204844A — 氨基杂芳基化合物及其制备方法与应用
Assigned to Shanghai Allist Pharmaceuticals Inc · Expires 2013-07-17 · 13y expired
What this patent protects
本发明涉及下式(I)氨基杂芳基化合物及其制备方法与应用,式中R 1 和R 3 的定义详见说明书。本发明所述氨基杂芳基化合物是肝细胞生长因子受体(c-Met)的抑制剂,具有良好的抑制c-Met作用和癌细胞增殖抑制作用,从而可用作治疗肿瘤和相关疾病的治疗剂。
USPTO Abstract
本发明涉及下式(I)氨基杂芳基化合物及其制备方法与应用,式中R 1 和R 3 的定义详见说明书。本发明所述氨基杂芳基化合物是肝细胞生长因子受体(c-Met)的抑制剂,具有良好的抑制c-Met作用和癌细胞增殖抑制作用,从而可用作治疗肿瘤和相关疾病的治疗剂。
Drugs covered by this patent
- Xalkori (crizotinib) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.